CYP 2.00% 25.5¢ cynata therapeutics limited

Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-17

  1. 450 Posts.
    lightbulb Created with Sketch. 142
    Cynata in a league of its own. While the rest of the 'big players' suck MSCs out of patient's bone marrow, cynata waits for the world to catch up. Most advanced ipsc derived cell product in the world. just read some of Jacques Galipeau's recent commentary.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
0.005(2.00%)
Mkt cap ! $45.80M
Open High Low Value Volume
25.5¢ 25.5¢ 25.5¢ $313 1.229K

Buyers (Bids)

No. Vol. Price($)
2 22209 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 36715 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.